Infectious Diseases (except HIV/AIDS)

Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China
Jing Lu, Louis du Plessis, Zhe Liu, Verity Hill, Min Kang, Huifang Lin, Jiufeng Sun, Sarah François, Moritz U G Kraemer, Nuno R Faria, John T McCrone, Jingju Peng, Qianlin Xiong, Runyu Yuan, Lilian Zeng, Pingping Zhou, Chuming Liang, Lina Yi, Jun Liu, Jianpeng Xiao, Jianxiong Hu, Tao Liu, Wenjun Ma, Wei Li, Juan Su, Huanying Zheng, Bo Peng, Shisong Fang, Wenzhe Su, Kuibiao Li, Ruilin Sun, Ru bai, Xi Tang, Minfeng Liang, Josh Quick, Tie Song, Andrew Rambaut, Nick Loman, Jayna Raghwani, Oliver G Pybus, Changwen Ke

medRxiv 2020.04.01.20047076; doi: https://doi.org/10.1101/2020.04.01.20047076

Add to Selected Citations
Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension
Guang Yang, Zihu Tan, Ling Zhou, Min Yang, Lang Peng, Jinjin Liu, Jingling Cai, Ru Yang, Junyan Han, Yafei Huang, Shaobin He

medRxiv 2020.03.31.20038935; doi: https://doi.org/10.1101/2020.03.31.20038935

Add to Selected Citations
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study
Tian Gu, Qiao Chu, Zhangsheng Yu, Botao Fa, Anqi Li, Lei Xu, Yaping He, Ruijun Wu

medRxiv 2020.03.23.20041848; doi: https://doi.org/10.1101/2020.03.23.20041848

Add to Selected Citations
If long-term suppression is not possible, how do we minimize mortality for COVID-19 and other emerging infectious disease outbreaks?
Andreas Handel, Joel C. Miller, Yang Ge, Isaac Chun-Hai Fung

medRxiv 2020.03.13.20034892; doi: https://doi.org/10.1101/2020.03.13.20034892

Add to Selected Citations
Japanese citizens’ behavioral changes and preparedness against COVID-19: How effective is Japan’s approach of self-restraint ?
Kaori Muto, Isamu Yamamoto, Miwako Nagasu, Mikihito Tanaka, Koji Wada

medRxiv 2020.03.31.20048876; doi: https://doi.org/10.1101/2020.03.31.20048876

Add to Selected Citations
Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information –an essential step to facilitate decision making
Maja von Cube, Marlon Grodd, Martin Wolkewitz, Derek Hazard, Jerome Lambert

medRxiv 2020.03.31.20049007; doi: https://doi.org/10.1101/2020.03.31.20049007

Add to Selected Citations
Clinical features, Diagnosis, and Treatment of COVID-19: A systematic review of case reports and case series
Azin Tahvildari, Mahta Arbabi, Yeganeh Farsi, Parnian Jamshidi, Saba Hasanzadeh, Tess Moore Calcagno, Mohammad Javad Nasiri, Mehdi Mirsaeidi

medRxiv 2020.03.28.20046151; doi: https://doi.org/10.1101/2020.03.28.20046151

Add to Selected Citations
Globalized low-income countries may experience higher COVID-19 mortality rates
Rodolfo Jaffé, Mabel Ortiz, Klaus Jaffé

medRxiv 2020.03.31.20049122; doi: https://doi.org/10.1101/2020.03.31.20049122

Add to Selected Citations
Assessment of prevalence and risk factors for intestinal parasitosis, malnutrition and anemia among school children in Ghindae area, Eritrea
Yafet Kesete, Huruy Tesfahiwet, Ghimja Fessehaye, Yohana Kidane, Yafet Tekle, Asmerom Yacob, Biemnet Seltene

medRxiv 2020.03.30.20042523; doi: https://doi.org/10.1101/2020.03.30.20042523

Add to Selected Citations
SARS-CoV-2 infection in health care workers: a retrospective analysis and model study
Yansen Bai, Xuan Wang, Qimin Huang, Han Wang, David Gurarie, Martial Ndeffo-Mbah, Fei Fan, Peng Fu, Mary Ann Horn, Shuai Xu, Anirban Mondal, Xiaobing Jiang, Hongyang Zhao

medRxiv 2020.03.29.20047159; doi: https://doi.org/10.1101/2020.03.29.20047159

Add to Selected Citations

Infectious Diseases (except HIV/AIDS)

Pages